Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Dutasteride is effective for treating hair loss.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Finasteride for female hair loss has low side effects, more research needed.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Finasteride may reduce bleeding after TURP, but more research needed.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Dutasteride reduces DHT more effectively than finasteride.

Combination therapies work better than single treatments for hair loss.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.